Decentralized Pilot Study of Triple Oral Metronomic Chemotherapy for Patients With Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population
Latest Information Update: 04 Jun 2025
At a glance
- Drugs Celecoxib (Primary) ; Erlotinib (Primary) ; Methotrexate (Primary)
- Indications Mouth neoplasm
- Focus Therapeutic Use
- Sponsors Mayo Clinic
Most Recent Events
- 04 Jun 2025 New trial record